HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noritoshi Sekido Selected Research

ONO-8055

1/2020Further characterization of a novel EP2 and EP3 receptor dual agonist, ONO-8055, on lower urinary tract function in normal and lumbar canal stenosis rats.
5/2018Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys.
8/2016Promising Effects of a Novel EP2 and EP3 Receptor Dual Agonist, ONO-8055, on Neurogenic Underactive Bladder in a Rat Lumbar Canal Stenosis Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noritoshi Sekido Research Topics

Disease

6Neoplasms (Cancer)
06/2015 - 03/2007
4Urinary Tract Infections (Urinary Tract Infection)
05/2024 - 04/2020
4Pathologic Constriction (Stenosis)
01/2020 - 03/2010
3Underactive Urinary Bladder
05/2018 - 11/2014
3Renal Cell Carcinoma (Grawitz Tumor)
04/2009 - 03/2007
2Overactive Urinary Bladder (Overactive Bladder)
03/2023 - 05/2011
2Prostatic Neoplasms (Prostate Cancer)
06/2015 - 08/2007
2Testicular Neoplasms (Testicular Cancer)
01/2013 - 07/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2010 - 11/2007
1Hemorrhage
05/2024
1Pain (Aches)
09/2023
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2023
1Infections
02/2022
1Intraoperative Complications
05/2018
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2018
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2018
1Rhabdomyosarcoma
05/2015
1Ureteral Obstruction
12/2012
1Rectal Neoplasms (Rectal Cancer)
03/2010
1Disease Progression
03/2010
1Fistula
03/2010
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2008
1Cysts
04/2008
1Pneumonia (Pneumonitis)
07/2006
1Inguinal Hernia (Direct Inguinal Hernia)
06/2005
1Inflammation (Inflammations)
08/2002
1Cystitis
08/2002
1Lymphatic Metastasis
01/2002

Drug/Important Bio-Agent (IBA)

3ONO-8055IBA
01/2020 - 08/2016
1Anti-Bacterial Agents (Antibiotics)IBA
05/2024
1SiliconesIBA
09/2023
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
02/2022
1Messenger RNA (mRNA)IBA
01/2020
1salicylhydroxamic acid (SHAM)IBA
01/2020
1ProstaglandinsIBA
05/2018
1Testosterone (Sustanon)FDA Link
01/2018
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2018
1Dinoprostone (PGE2)FDA Link
08/2016
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2014
1Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2014
1Oxidoreductases (Dehydrogenase)IBA
01/2013
1propiverineIBA
05/2011
1Interferon-alpha (Interferon Alfa)IBA
04/2009
1Sildenafil Citrate (Viagra)FDA Link
06/2008
1Prostate-Specific Antigen (Semenogelase)IBA
08/2007
1Hormones (Hormone)IBA
08/2007
1Prednisone (Sone)FDA LinkGeneric
08/2007
1Docetaxel (Taxotere)FDA Link
08/2007
1Bleomycin (Blenoxane)FDA LinkGeneric
07/2006
1Etoposide (VP 16)FDA LinkGeneric
07/2006
1Cisplatin (Platino)FDA LinkGeneric
07/2006

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2014 - 01/2002
3Catheters
05/2024 - 01/2023
3Prostatectomy (Retropubic Prostatectomy)
05/2018 - 06/2005
3Therapeutics
05/2015 - 11/2007
2Stents
12/2012 - 03/2010
2Nephrectomy
04/2008 - 03/2007
1Solid-State Lasers
03/2023
1Urinary Catheters
01/2023
1Conservative Treatment
04/2020
1Hysterectomy
05/2018
1Punctures
06/2015
1Proton Therapy
05/2015
1Nephroureterectomy
07/2010
1Proctectomy
03/2010
1Intramuscular Injections
04/2009
1Induction Chemotherapy
07/2006
1Intravesical Administration
08/2002